 |
Publisher: Peytchinski, Gospodin Iliev
ISSN: 1312 773X (Online)
Year: 2013, vol. 19, issue 2
Subject Collection: Oral and Dental Medicine
Pages: 295-297
DOI: 10.5272/jimab.2013192.295
Published online: 27 May 2013
J of IMAB 2013; 19(2):295-297
AMLODIPIN-INDUCED GINGIVAL OVERGROWTH AND APPLICATION OF ER:YAG LASER IN THE TREATMENT PROTOCOL.
Elena I. Firkova1
, Maria S. Panchovska2, Hristo Daskalov3
1) Department of Periodontology and Oral Diseases, Faculty of Dental Medicine, 2) Department of Internal Diseases, Faculty of Medicine, 3) Department of Oral Surgery, Faculty of Dental Medicine, Medical University Plovdiv, Bulgaria.
ABSTRACT:
Gingival overgrowth (GO) is one of the most important clinical features of gingival pathology. Amlodipine is a comparatively new III generation calcium channels blocker, used for management of cardiovascular disorders. Although it is considered safe, it can also rarely induce GO. A case of severe amlodipine-induced GO, complicated by inflammatory changes due to plaque accumulation is presented in a 54 years old patient.
Treatment was performed as follows: drug substitution; initial periodontal therapy –scaling and root planning (reduction of inflammatory component in the gingival tissues); Er:YAG laser-performed gingivectomy and gingivoplasty; maintenance care. The healing process went uneventful and the postoperative results were extremely esthetically and functionally satisfactory.
Key words: amlodipine, gingival overgrowth, laser-assisted surgery.
- Download FULL TEXT /PDF 2620 KB/
Please cite this article as:
Firkova EI, Panchovska MS, Daskalov H. Amlodipin-induced gingival overgrowth and application of Er:YAG laser in the treatment protocol. J of IMAB. 2013; 19(2):295-297. doi: 10.5272/jimab.2013192.295
Correspondence to: Dr Elena Firkova, Department of Periodontology and Oral Diseases, Faculty of Dental Medicine, Medical University Plovdiv; 3, Hristo Botev Blvr., Plovdiv, Bulgaria;
REFERENCES:
1. Dongari-Bagtzoglou A; Research, Science and Therapy Committee, AAPeriodontology. Drug associated gingival enlargement. J Periodontol. 2004 Oct;75(10):1424–31. [PubMed] [CrossRef]
2. Ellis JS, Seymour RA, Thomason JM, Monkman SC, Idle JR. Gingival sequestration of amlodipine and amlodipine-induced gingival overgrowth. Lancet. 1993 Apr 24;341(8852):1102-3. [PubMed]
3. Seymour RA, Ellis JS, Thomason JM, Monkman S, Idle JR. Amlodipine-induced gingival overgrowth. J Clin Periodontol. 1994 Apr;21(4):281-3. [PubMed]
4. Lafzi A, Farahani RM, Shoja MA. Amlodipine-induced gingival hyperplasia. Med Oral Patol Oral Cir Bucal. 2006 Nov 1;11(6):E480-2. [PubMed]
5. Ellis JS, Seymour RA, Steele JG, Robertson P, Butler TJ, Thomason JM. Prevalence of gingival overgrowth induced by calcium channel blockers: a community-based study. J Periodontol. 1999 Jan;70(1):63-7. [PubMed] [CrossRef]
6. Triveni MG, Rudrakshi C, Mehta DS. Amlodipine-induced gingival overgrowth. J Indian Soc Periodontol. 2009 Sep-Dec; 13(3): 160–163. [PubMed] [CrossRef].
Received: 20 March 2013
Published online: 27 May 2013